News search

E.g., 22/11/2024
E.g., 22/11/2024
Marta Amorós Pérez, Virginia Zorita, Nuria Matesanz, Marian Zuriaga y José Javier Fuster.
About the CNIC
23 Dec 2020

The project will investigate the role of clonal hematopoiesis—the formation of mutated hematopoietic stem-cell clones promoted by anti-cancer therapies—in the development of atherosclerosis and associated cardiovascular disease

Research
27 Oct 2020

The finding provides a basis for mitigating the loss of muscle regenerative capacity in very elderly people.

Research
22 Oct 2020

CNIC scientists have discovered previously unsuspected actions of the immune system that help to maintain organ health

Research
16 Oct 2020

Researchers of IDIBAPS, the University of Barcelona and CNIC describes a new mechanism of innate immunity by which cells fight viruses and bacteria.


Research
17 Sep 2020

The results published in Nature Metabolism could be useful to design new treatments for the obese and overweight, and for some associated pathologies, including fatty liver disease and type 2 diabetes

Research
16 Sep 2020

The study published in Cell shows that macrophages, a type of immune cell, help cardiac cells to get rid of their waste material, and that this maintains the metabolic and contractile properties of the heart

Research
30 Jul 2020

CNIC study shows that selection between mitochondrial genomes depends on how each type of mitochondria affects cell metabolism

Research
29 May 2020

The researcher Alejandro Sánchez Alvarado is one of the greatest experts in the study of the mechanisms involved, cellular and biological, in regeneration in the planaria model

Research
28 Apr 2020

CNIC scientists, working with international partners, have developed a new experimental mouse model that allows them to study how cells sense, interpret, and generate mechanical forces

Microscopía confocal mostrando un macrófago peritoneal de un ratón deficiente en RXR, donde se observa un alto contenido de lípidos (verde) dentro de vesículas ácidas (rojo).
Research
3 Apr 2020

Published in Nature Communications, the study suggests that it may be possible to regulate the number and activity of these macrophages with drugs that modulate the nuclear receptor RXR